Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peripheral nociceptive sensory neurons, commonly known as nociceptors, are specialized neurons of the peripheral nervous system that detect potentially damaging (noxious) stimuli—including chemical, thermal, and mechanical threats—and convey these signals toward the central nervous system to initiate the sensation of pain[3][4][5]. Nociceptors reside mainly in dorsal root and trigeminal ganglia and have a pseudounipolar morphology, allowing their peripheral fibers to terminate in tissues (e.g., skin, viscera), while their central fibers project to the spinal cord[4][5][6][7]. There are two main types—Aδ fibers (myelinated, fast-conducting, sharp pain) and C fibers (unmyelinated, slow, dull pain)[3][5][6]. These neurons also play key roles in neuroimmune communication by releasing neuropeptides such as CGRP and substance P, influencing inflammation, tissue repair, and in some contexts, pathological pain[1][7]. As research shows, nociceptors are a primary therapeutic target for pain control, and drugs targeting their ion channels and peptide release mechanisms are used or investigated for analgesia[7]. "Peripheral nociceptive sensory neurons" is a collective anatomical/functional category rather than a single molecule or canonical drug target, but it remains a central concept in pain pharmacology and neurobiology[2][3][4]. Note on terminology: The queried term is not a canonical molecule or standardized drug target, but refers to a diverse population of sensory neurons. For structured database use, it should be mapped to "Nociceptor" (or synaptic entities such as "Dorsal root ganglion nociceptor") as used in the literature[3][5][7].
Sodium channel blockade (lidocaine, Nav1.7 inhibitors), Desensitization/agonism of TRP channels (capsaicin), Calcium channel blockade (ziconotide, gabapentinoids), Inhibition of neuropeptide release, Inhibition of action potential conduction
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peripheral nociceptive sensory neuron.